Brittany Griffith
Family · Madison, WVNPI 1104464999
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 99.8% of the total across 470 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 40 manufacturers, the largest accounting for just 18.2% — the pattern of someone who eats at a lot of different presentations. Among family clinicians in WV with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 470 payments — averaging $17.53 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AstraZeneca$2K
- Pfizer$1K
- Boehringer Ingelheim$746
- Salix Pharmaceuticals, A Division Of Bausch Health US, LLC$481
- Johnson & Johnson$430
- Novartis$382
- plus $4K from 34 others
What the payments were for
- Food & beverage$8,223100%
- Education$170%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AstraZeneca | 54 | $1,501 |
| Pfizer | 83 | $1,176 |
| Boehringer Ingelheim | 35 | $746 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 35 | $481 |
| Johnson & Johnson | 24 | $430 |
| Novartis | 21 | $382 |
| GSK | 28 | $376 |
| Bayer | 32 | $349 |
| Exact Sciences | 15 | $316 |
| Novo Nordisk | 13 | $225 |
| ZOLL Services LLC (a/k/a ZOLL Lifecor Corp) | 19 | $209 |
| Amarin Pharma, Inc. | 12 | $185 |
| Mylan Specialty L.p. | 8 | $165 |
| AbbVie | 7 | $147 |
| Verona Pharma, Inc. | 9 | $146 |
| Esperion Therapeutics, Inc. | 8 | $137 |
| Lexicon Pharmaceuticals, Inc. | 6 | $134 |
| Lundbeck LLC | 7 | $115 |
| Shield Therapeutics Inc | 2 | $96 |
| Baxter Healthcare | 5 | $84 |
| Merck | 4 | $82 |
| Axsome Therapeutics, Inc. | 3 | $72 |
| Paratek Pharmaceuticals, Inc. | 4 | $71 |
| Averitas Pharma Inc. | 4 | $70 |
| Lilly USA, LLC | 4 | $64 |
| Dexcom, Inc. | 3 | $63 |
| Daiichi Sankyo Inc. | 3 | $61 |
| Astellas Pharma US Inc | 3 | $55 |
| Biohaven Pharmaceutical Holding Company Ltd. | 2 | $43 |
| Amgen | 3 | $42 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $41 |
| Tactile Systems Technology Inc | 2 | $30 |
| Almatica Pharma LLC | 2 | $29 |
| Eisai Inc. | 2 | $28 |
| Harmony Biosciences LLC | 1 | $18 |
| Insmed, Inc. | 1 | $17 |
| Heartflow, Inc. | 1 | $15 |
| Jazz Pharmaceuticals Inc. | 1 | $14 |
| Phathom Pharmaceuticals, Inc. | 1 | $13 |
| Ambu Inc. | 1 | $10 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$8,241 in reported general payments places this provider in the 95th percentile of 1,507 family providers in West Virginia.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| OzempicSemaglutide | 145 | $143,046 |
| FarxigaDapagliflozin Propanediol | 147 | $88,837 |
| JardianceEmpagliflozin | 79 | $63,461 |
| Spiriva HandihalerTiotropium Bromide | 64 | $41,320 |
| Trelegy ElliptaFluticasone/Umeclidin/Vilanter | 45 | $38,658 |
| EliquisApixaban | 60 | $36,370 |
| Janumet XrSitagliptin Phos/Metformin Hcl | 46 | $31,569 |
| XareltoRivaroxaban | 49 | $29,750 |
| EntrestoSacubitril/Valsartan | 43 | $28,952 |
| LinzessLinaclotide | 35 | $28,376 |
| Xigduo XrDapaglifloz Propaned/Metformin | 40 | $27,364 |
| JanuviaSitagliptin Phosphate | 40 | $26,659 |
| TradjentaLinagliptin | 37 | $21,955 |
| JanumetSitagliptin Phos/Metformin Hcl | 34 | $19,879 |
| TrulicityDulaglutide | 13 | $18,298 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Novo NordiskOzempic | $225 | $143,046145 claims |
| Boehringer IngelheimJardiance, Tradjenta, Synjardy Xr, Stiolto Respimat, Combivent Respimat | $746 | $114,243156 claims |
| AstraZenecaFarxiga, Breztri Aerosphere, Symbicort | $1,501 | $112,145210 claims |
| MerckJanumet Xr, Januvia, Janumet | $82 | $78,107120 claims |
| GSKTrelegy Ellipta | $376 | $38,65845 claims |
| PfizerEliquis | $1,176 | $36,37060 claims |
| Lilly USA, LLCTrulicity, Mounjaro | $64 | $35,43030 claims |
| AbbVieLinzess, Synthroid | $147 | $30,62978 claims |
| Johnson & JohnsonXarelto | $430 | $29,75049 claims |
| NovartisEntresto | $382 | $28,95243 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 1,507 family providers in West Virginia.
Other family in Madison
- Ashley ComerCharleston$213K
- Dana CruseParkersburg$109K
- Sarah KnightCharleston$99K
- Star RoeBarboursville$55K
- Angela SettleCharleston$51K
- Amber DuncanCross Lanes$44K
- Jennifer FieldsHuntington$32K
- Gina LatheyScott Depot$31K
- Jodi BillerScott Depot$29K
- Misty BareboHuntington$25K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.